SynthesisOncology and therapy2026

Venetoclax Plus Rituximab for Relapse/Refractory Chronic Lymphocytic Leukemia: A Systematic Review and Network Meta-analysis of Treatments Available in Brazil.

Bruno M Barros et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.